Alkeran and graft versus host disease 
Alkeran and graft versus host disease Patient Reports February 11, 2012
Alkeran Side Effects Report #6068704-5
Alkeran side effect was reported by a Consumer or non-health professional from JAPAN on Jan 30, 2009. Male patient, child 8 years of age, was diagnosed with transplant, prophylaxis against graft versus host disease and was treated with Alkeran. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, glomerulonephritis membranous, graft versus host disease, hypertensive encephalopathy, hypoproteinaemia, nephrotic syndrome, oral disorder, proteinuria, rash
. Alkeran dosage: unknown. During the same period patient was treated with CYCLOSPORINE, TACROLIMUS HYDRATE, BUSULFAN, FLUDARA, METHOTREXATE, PREDNISOLONE. Patient recovered.Alkeran Side Effects Report #6079175-7
Alkeran side effect was reported by a Consumer or non-health professional from JAPAN on Feb 13, 2009. Male patient, child 8 years of age, was diagnosed with transplant, prophylaxis against graft versus host disease and was treated with Alkeran. After drug was administered, patient experienced the following side effects: antinuclear antibody increased, glomerulonephritis membranous, graft versus host disease, hypertensive encephalopathy, hypoproteinaemia, nephrotic syndrome, oral disorder, proteinuria, rash
. Alkeran dosage: unknown. During the same period patient was treated with CYCLOSPORINE, TACROLIMUS HYDRATE, BUSULFAN, FLUDARA, METHOTREXATE, PREDNISOLONE. Patient recovered.Alkeran Side Effects Report #4964526-4
Alkeran side effect was reported by a Physician from JAPAN on Nov 01, 2005. Male patient, 42 years of age, weighting 158.7 lb, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood bilirubin increased, graft versus host disease, liver disorder. Alkeran dosage: 80MGM2 PER DAY. During the same period patient was treated with FUNGIZONE, TARGOCID, FUNGUARD, OMEGACIN, FLUDARA, NEUTROGIN. Patient recovered.
Alkeran Side Effects Report #5145431-X
Alkeran side effect was reported by a Health Professional from NETHERLANDS on Oct 19, 2006. Male patient, 16 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, mucosal inflammation, multi-organ failure, sepsis
, venoocclusive disease. Alkeran dosage: 140 MG/M2/CYCLIC. During the same period patient was treated with MYLERAN, CYCLOPHOSPHAMIDE, CAMPATH, CLONAZEPAM. Patient died.Alkeran Side Effects Report #5145418-7
Alkeran side effect was reported by a Consumer or non-health professional from NETHERLANDS on Oct 19, 2006. Male patient, 13 years of age, was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, sepsis
. Alkeran dosage: 140 MG/M2 / CYCLIC /. During the same period patient was treated with MYLERAN, CYCLOPHOSPHAMIDE, CLONAZEPAM. Patient died.Alkeran Side Effects Report #5034756-4
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, neutrophil count decreased, platelet count decreased, pneumonia
. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5034757-6
Alkeran side effect was reported by a Physician from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, hepatotoxicity, mucosal inflammation. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034758-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased, sepsis
. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5034759-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034760-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease, graft versus host disease in skin, mucosal inflammation, platelet count decreased. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5034761-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, hepatotoxicity, pneumonia
. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYSTE IG. Patient recovered.Alkeran Side Effects Report #5034762-X
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #5035042-9
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Male patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, hepatotoxicity, leukaemia recurrent, mucosal inflammation, pneumonia
, stem cell transplant, surgical procedure repeated. Alkeran dosage: 150 MG/M2. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.Alkeran Side Effects Report #5035047-8
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in intestine, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035053-3
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: diarrhoea, graft versus host disease, mucosal inflammation, pneumonia aspergillus. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE. Patient recovered.
Alkeran Side Effects Report #5035063-6
Alkeran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, graft versus host disease in skin, mucosal inflammation. Alkeran dosage: 150 MG/M2 /. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE, ANTITHYMOCYTE IG. Patient recovered.
Alkeran Side Effects Report #4853329-7
Alkeran side effect was reported by a Physician from JAPAN on Dec 02, 2005. Male patient, child 6 years of age, was treated with Alkeran. After drug was administered, patient experienced the following side effects: diabetes mellitus insulin-dependent, engraftment syndrome, graft versus host disease, thrombotic microangiopathy. Alkeran dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE, TOTAL BODY IRRADIATION, INSULIN, BONE MARROW TRANSPLANT. Patient recovered.
Alkeran Side Effects Report #4845329-8
Alkeran side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 53 years of age, weighting 191.8 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood creatinine increased, c-reactive protein increased, convulsion, cytomegalovirus viraemia, disseminated intravascular coagulation, graft versus host disease, haemorrhage, pneumonia cytomegaloviral, prothrombin level decreased. Alkeran dosage: unknown. During the same period patient was treated with TACROLIMUS HYDRATE, HORSE IMMUNOGLOBULIN, AZACTAM, CARBENIN, CYMERIN. Patient died on 03/18/2003.
Alkeran Side Effects Report #4883337-1
Alkeran side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 53 years of age, weighting 191.8 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood creatinine increased, c-reactive protein increased, convulsion, cytomegalovirus viraemia, disseminated intravascular coagulation, graft versus host disease, haemorrhage, pneumonia cytomegaloviral, prothrombin time prolonged. Alkeran dosage: unknown. During the same period patient was treated with TACROLIMUS HYDRATE, HORSE IMMUNOGLOBULIN, AZACTAM, CARBENIN, CYMERIN. Patient died on 03/18/2003.
Alkeran Side Effects Report #4963078-2
Alkeran side effect was reported by a Physician from JAPAN on Nov 28, 2005. Male patient, 53 years of age, weighting 191.8 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: blood creatinine increased, c-reactive protein increased, coma, convulsion, cytomegalovirus viraemia, disseminated intravascular coagulation, graft versus host disease, haemorrhage, pneumonia cytomegaloviral. Alkeran dosage: 60MGM2 PER DAY. During the same period patient was treated with TACROLIMUS HYDRATE, HORSE IMMUNOGLOBULIN, CYMERIN, CYCLOSPORINE. Patient died on 03/18/2003.
Alkeran Side Effects Report #4881527-5
Alkeran side effect was reported by a Physician from JAPAN on Dec 16, 2005. Female patient, child 2 years of age, weighting 19.62 lb, was treated with Alkeran. After drug was administered, patient experienced the following side effects: graft versus host disease, petechiae, thrombotic microangiopathy. Alkeran dosage: 50MG PER DAY. During the same period patient was treated with FLUDARA, TACROLIMUS HYDRATE, NEUTROGIN, CARBENIN, DIFLUCAN, VANCOMYCIN, ZOVIRAX. Patient was hospitalized. Patient recovered.